BIVI
Biovie IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.82M
P/E Ratio
—
EPS
$-3.79
Beta
0.72
52W High
$11.60
52W Low
$1.06
50-Day MA
$1.51
200-Day MA
$1.50
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Biovie Inc
BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States. The company is headquartered in Santa Monica, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-20.37M |
| Operating Margin | 0.00% |
| Return on Equity | -106.40% |
| Return on Assets | -61.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.07 |
| Price-to-Book | 0.80 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -11.66 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $7.54M |
| Float | $7.50M |
| % Insiders | 0.36% |
| % Institutions | 13.94% |
Historical Volatility
HV 10-Day
89.69%
HV 20-Day
80.99%
HV 30-Day
78.99%
HV 60-Day
82.59%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 6/13/2026